Momentum Bioscience is focused on developing rapid tests for bloodstream infection in patients suspected of sepsis.
SepsiSTAT® is our direct-from-blood, rapid screening technology, providing actionable results for suspected sepsis patients.
SepsiSTAT® contains our three proprietary capabilities:
- Sensitive and universal microbial capture
- Universal detection of viable microorganisms
- Organism profiling
Only by using Momentum’s proprietary universal pathogen capture, detection & identification capabilities can all patients suspected of sepsis expect actionable results for bloodstream infection in <3 hours. Not days.
This will have a significant impact on patient management, the management of antibiotics and help mitigate the problem of increasing antimicrobial resistance.
Momentum is seeking partners for joint commercialisation.
Contact Information:
Address:
10 Fenlock Court,
Blenheim Office Park,
Long Hanborough,
Oxfordshire,
OX29 8LN
Tel: +44 (0)2921 677 910
Email: hbennett@momentumbio.co.uk
